Key takeaways What’s the difference between the Wegovy injection, Wegovy pill, and compounded semaglutide? Quick answer: All three contain semaglutide. The Wegovy pill is a daily oral tablet ($149/mo intro), the Wegovy injection is a weekly shot ($349/mo cash pay), and Wegovy HD is a higher-dose weekly shot for people who have tolerated standard Wegovy […]
By Astra Editorial Team
Published:
Updated:
Quick answer: All three contain semaglutide. The Wegovy pill is a daily oral tablet ($149/mo intro), the Wegovy injection is a weekly shot ($349/mo cash pay), and Wegovy HD is a higher-dose weekly shot for people who have tolerated standard Wegovy ($399/mo cash pay). Compounded semaglutide is the same active ingredient prepared by a licensed pharmacy with custom dosing, typically $96–$300/mo.
All three use semaglutide (the same molecule) but they differ in form, dose, and price. Wegovy injection (2.4mg) has been on the market since 2021 and has the deepest clinical record. The Wegovy pill (25mg) launched in January 2026 and is the first FDA-approved oral GLP-1 for weight loss. Wegovy HD (7.2mg injection) got FDA approval in March 2026 and started shipping in April.
Compounded semaglutide is the same active ingredient prepared by a licensed compounding pharmacy under a prescription from a licensed provider. It’s typically dispensed in a vial with a syringe, and your dose is set based on your weight, response, and tolerance; not on Novo Nordisk’s fixed schedule. That flexibility is one of the reasons telehealth providers built their offerings around it.
Astra’s compounded semaglutide starts at $96/month, filled by a US-licensed 503A pharmacy and reviewed by a licensed clinician.
See if compounded fits → No hidden fees. Cancel anytime.Compounded semaglutide is the cheapest at $96-$300/month. Wegovy HD delivers the highest weight loss at 18.8%. Wegovy pill is the only oral option. Wegovy 2.4mg is the most-prescribed injectable.
| Feature | Wegovy Pill (25mg) | Wegovy Injection (2.4mg) | Wegovy HD (7.2mg) | Compounded semaglutide |
|---|---|---|---|---|
| Form | Daily oral tablet | Weekly injection | Weekly injection | Weekly injection |
| FDA-approved? | Yes | Yes | Yes | No (custom-compounded) |
| Average weight loss | ~13.6% | ~15.5% | ~18.8% | Depends on dose |
| Starting price | $149/mo intro | $349/mo cash pay | $399/mo cash pay | $96-$300/mo |
| Custom dosing | No | No | No | Yes |
| Who can use it | Adults with obesity or overweight + comorbidity | Adults & kids 12+ | Adults who tolerated 2.4mg for 4+ weeks | Adults (per provider criteria) |
Quick answer: The Wegovy pill delivers around 13.6% weight loss at 64 weeks in the OASIS 4 trial. The Wegovy injection delivers about 15.5%. They’re close, but the pill requires a strict morning routine (empty stomach, small sip of water, no food or other meds for 30 minutes) or absorption drops.
The Wegovy pill works almost as well as the standard injection but only if you take it correctly every morning. In the OASIS 4 trial, adults on oral semaglutide 25mg lost about 13.6% of their body weight at 64 weeks, compared to 2.2% on placebo. Injectable Wegovy 2.4mg landed at about 15.5% in STEP UP.
Keep in mind that the Wegovy pill only absorbs well if you follow the exact routine. The prescribing information tells you to take it first thing in the morning, on an empty stomach, with no more than 4 ounces of water, and wait 30 minutes before eating, drinking anything else, or taking other oral meds.
A 2021 pharmacokinetics analysis found oral semaglutide’s bioavailability is around 0.8%, meaning your body absorbs less than 1% of what you swallow. That’s why the daily dose is so much higher than the injection.
If your mornings are predictable, the pill works. Otherwise, it might be easier to stick with the once-a-week injection.
Quick answer: Wegovy HD adds about 3 percentage points of weight loss over standard Wegovy, averaging 18.8% vs. 15.5% at 72 weeks. About 31% of people on HD lose 25% or more of their body weight. But you can only access HD after tolerating the 2.4mg dose for at least four weeks.
Wegovy HD adds about 3 percentage points of weight loss over standard Wegovy, roughly 19% vs. 16% over 72 weeks. In the STEP UP trial, adults with obesity (no diabetes) lost an average of 18.8% on Wegovy HD vs. 15.5% on the 2.4mg dose. If they stayed on treatment the full 72 weeks, the numbers were 20.7% and 17.5%. About 31% of people on HD hit 25% or greater weight loss.
But HD isn’t a starting dose. The FDA label requires you to tolerate the standard 2.4mg dose for at least four weeks before stepping up, and your provider has to decide additional weight loss is clinically needed. That puts HD out of reach for anyone just starting treatment.
One side effect to know about is altered skin sensations (burning, tingling, sensitive skin), which were reported by 22% of people on HD vs. 6% on 2.4mg and 0.3% on placebo. They usually resolved on their own or with a dose reduction, but the FDA is still investigating why this happens at higher doses.
There’s a useful comparison here: compounded semaglutide can be dosed at custom strengths your provider sets based on how you respond, which means you don’t have to spend months titrating up Novo’s fixed schedule to reach a dose that works for you. If you and your provider decide a higher dose makes sense, you can get there directly.
Quick answer: Yes, when the dose and quality match. Compounded semaglutide uses the same active ingredient as Wegovy, so people on comparable doses through reputable telehealth providers regularly report weight loss in the 15-20% range. The provider and pharmacy you choose matters more than the category itself.
Compounded semaglutide uses the same active molecule as Wegovy, so when dose and quality are matched, results are comparable. Some patients on compounded semaglutide through reputable telehealth platforms have reported weight loss in the 15-20% range at similar doses to Wegovy.
What varies between providers is what surrounds the semaglutide. Meaning the inactive ingredients, the pharmacy’s sterility standards, the dosing accuracy, and the level of medical oversight.
Look for telehealth platforms that work with state-licensed compounding pharmacies, ideally ones registered with the FDA as outsourcing facilities or accredited through the Pharmacy Compounding Accreditation Board. Reputable providers also include real prescriber visits, dose titration based on your response, and clear ingredient sourcing.
A 2025 study in Pharmacoepidemiology and Drug Safety noted that compounded GLP-1 use is often documented in telehealth records but not in primary care charts, which mostly reflects that telehealth has become its own care channel, separate from the traditional primary-care system.
If you’re getting compounded semaglutide, share your prescription with your primary doctor so they can monitor along with your telehealth provider.
Quick answer: Look for real prescriber oversight, a licensed US compounding pharmacy with PCAB accreditation or FDA 503B registration, semaglutide base (not salts or research-grade material), transparent pricing, and easy access to your provider for dose changes.
The quality of compounded semaglutide depends almost entirely on the pharmacy and telehealth provider you choose. A few markers of a reputable source:
Quick answer: There’s no such thing as “compounded Wegovy.” Wegovy is a brand name owned by Novo Nordisk. What people call “compounded Wegovy” is actually compounded semaglutide, the same active ingredient prepared by a licensed compounding pharmacy. There’s no FDA-approved generic version of Wegovy.
Wegovy is a brand name owned by Novo Nordisk, and only Novo Nordisk makes Wegovy. “Compounded Wegovy” is a colloquial term that usually means compounded semaglutide, the same active ingredient prepared by a compounding pharmacy. It’s a separate product. Anyone marketing “generic Wegovy” is using the wrong term; there’s no FDA-approved generic of Wegovy yet.
Quick answer: No. The FDA declared the semaglutide shortage resolved in February 2025, which narrowed but did not eliminate the pathway for compounded versions. Compounded semaglutide is still legally available through 503A and 503B compounding pharmacies when there’s a documented clinical reason a patient needs a custom preparation.
No, but the rules changed in February 2025. During the official semaglutide shortage (2022 to early 2025), compounding pharmacies could broadly produce copies to meet demand. Once the FDA declared the shortage resolved, that broad pathway closed.
Compounded semaglutide is still legally available through 503A and 503B compounding pharmacies when there’s a documented clinical reason a patient needs a custom preparation. For example, a different dose, a different formulation, or an allergy to an inactive ingredient in the brand-name product.
The market is more selective than it was in 2023, and the providers still operating in it tend to be more established and more accountable.
Quick answer: Yes. Since the active ingredient is the same, most people transition smoothly. The main change is losing the ability to fine-tune your dose, since Wegovy comes in prefilled pens with fixed doses.
Talk to your prescriber about your current dose. If you’ve been on something comparable to 2.4mg, you’ll likely start at that level rather than re-titrating from 0.25mg. If you’ve been on a smaller microdose, you may need a more gradual ramp to avoid stomach side effects. Wegovy comes in prefilled pens with fixed doses, so you’ll no longer be able to fine-tune your dose week to week.
Quick answer: Wegovy HD delivers the highest average weight loss (18.8%), but it’s only available after tolerating standard Wegovy for 4+ weeks. For most people starting out, compounded semaglutide from a vetted telehealth provider is the best value: the same active ingredient with dose flexibility at $96-$300/month vs. $349+/month for brand-name Wegovy.
On raw weight-loss numbers, Wegovy HD wins. But it’s also the most expensive and the most restrictive on access. Here’s how to think about it by use case:
For most people starting out, compounded semaglutide from a vetted telehealth provider is a strong value play. You get the same molecule with the option to dose to your response, at less than a third of brand-name pricing in many cases.
The best fit depends on your budget, whether your insurance covers brand-name, how you feel about injections, and what you’re trying to achieve. A licensed clinician at Astra reviews your health profile and walks you through it. No pressure, no upsell.
Talk to a clinician →Quick answer: The two real alternatives are compounded semaglutide (same active ingredient, lower price) and tirzepatide/Zepbound (different molecule, often greater weight loss). If you want to stay on semaglutide and reduce cost, compounded is the answer. If you’re open to a different drug class, tirzepatide is worth discussing with your provider.
Tirzepatide is a different molecule that targets two gut hormones instead of one, and head-to-head trials have shown it edges out semaglutide for weight loss. If you want to stay on semaglutide specifically and you’re focused on price, compounded semaglutide is the practical alternative.
Quick answer: Most reputable telehealth providers charge $96-$300/month for compounded semaglutide, depending on dose, pharmacy, and whether prescriber visits are bundled. Brand-name Wegovy injection runs $349-$1,500/month depending on how you pay. Here’s a breakdown of GLP-1 pricing as of writing.
If you have commercial insurance that covers Wegovy and a manufacturer copay card brings your cost to $25 per month, brand-name Wegovy is the cheapest path.
If you’re paying cash and want a brand-name option, the Wegovy pill at $149 per month through TrumpRx is the most affordable starting point. Just be sure you can stick to the morning routine.
If you’re paying cash and open to compounded GLP-1 from a licensed 503A pharmacy, $96-$300 per month is realistic for compounded semaglutide. You get the same active ingredient as Wegovy at a fraction of the price, with the option of custom dosing your prescriber adjusts to your response.
For more on what to expect from compounded treatment, see our full guide on compounded GLP-1 medications and what to expect on your first month on GLP-1.
If you’re considering compounded GLP-1 treatment, Astra (try-astra.com) prescribes through licensed clinicians at Wasef Health, PC, and fills compounded prescriptions through VialsRx, a US-licensed 503A pharmacy. Compounded semaglutide starts at $96 per month on Astra’s 3-month starter plan. Microdose semaglutide starts at $89 per month on the 6-month plan. Brand-name Wegovy is also available through Astra’s weight loss program.
Astra’s compounded semaglutide starts at $96/month, clinician-reviewed and pharmacy-verified. If that’s the fit for you, we’ll tell you. If it’s not, we’ll tell you that too.
Start your health profile Takes about 5 minutes.Compounded semaglutide uses the same active ingredient as Wegovy, so at comparable doses results are similar. What changes the outcome is the quality of the pharmacy and the medical oversight from your provider. Choose carefully and you can expect comparable results at a fraction of the cost.
Wegovy is a fixed-dose, FDA-approved product made by Novo Nordisk. Compounded GLP-1s are custom-prepared by a licensed compounding pharmacy under a prescription, often with the ability to adjust dose to your response. Both can contain semaglutide as the active ingredient.
Compounded is usually cheaper and allows dose customization. Brand-name Wegovy comes with FDA approval and a fixed dosing schedule. The right choice depends on your priorities around price, flexibility, and oversight.
No. The Wegovy label explicitly says you should not combine semaglutide products or take Wegovy with any other GLP-1 medicine.
Because your body only absorbs about 1% of an oral dose. The Wegovy injection puts semaglutide directly under your skin, where almost all of it gets absorbed. The Wegovy pill has to survive your stomach and cross the stomach lining, so the dose is much higher to make up for the loss.
For the pill, skip the missed dose and take the next one the following morning. For the injection, if your next dose is more than two days away, take the missed dose right away; if it’s less than two days away, skip it and resume on your regular day.
This article is for educational purposes only and does not constitute medical advice. Consult a licensed physician regarding any medical condition or treatment.